Registration & Light Continental Breakfast
8:00 am- 8:30 am
Lectures
8:30 am – 12:20 pm
Dawe Auditorium
South Washington Professional Building
2720 S. Washington, Ste. 200
Lansing, MI 48910
PURPOSE and TARGETED AUDIENCE
This half-day conference is designed specifically for primary care physicians, internal medicine physicians, rheumatologists, endocrinologists, orthopedic surgeons and other interested health care professionals with an update of the most current topics in the treatment of osteoporosis. The information will be practical and applicable to daily practice. A comprehensive course syllabus will be provided to each participant.
ACCREDITATION
The Ingham Regional Medical Center, is accredited by the Michigan State Medical Society Committee on CME Accreditation to provide continuing medical education for physicians. The Ingham Regional Medical Center designates this educational activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This program anticipates being approved for 4.0 hours of AOA Category 1A credit pending approval by the AOA CME.
Program Director
Richard A. Pittsley, MD, FACR
Associate Clinical Professor of Medicine, MSU College of Human Medicine
Voted into Best Doctors in America by fellow physicians
Program Coordinator
Peggy Mariucci
Department of Continuing Medical Education
Ingham Regional Medical Center
SESSION
Moderator: Richard A Pittsley, MD
Educational Objectives:
At the conclusion of this session the participant will be able to:
1. Review recent advances regarding osteoporosis
2. Discuss current therapies for osteoporosis
3. Describe importance of treating and preventing osteoporosis in men and osteoporosis secondary to glucocorticoid
4. Define current oral and parenteral bisphosphonates
8:00 Registration
8:30 Osteoporosis – What You Need to Know in 2008
- Allen H. Morton, DO
9:30 Management of Osteoporosis – State of the Art
- Allan H. Morton, DO
10:30 Diagnosis and Treatment of Male Osteoporosis
- Richard A. Pittsley, MD, FACR
11:30 Glucocorticoid Induced Osteoporosis
- Richard A. Pittsley, MD. FACR
12:30 Course Evaluation-Conference Adjourns
FACULTY
Richard A. Pittsley, MD, FACR
Founding Fellow, American College of Rheumatology
Associate Clinical Professor of Medicine, MSU College of Human Medicine
Voted into Best Doctors in America by fellow physicians
Allan H. Morton, DO
Rheumatologist, Warren, MI
CONFLICT of INTEREST
It is the policy of Ingham Regional Medical Center and the Department of Continuing Medical Education to ensure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any Ingham Regional Medical Center sponsored program are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have direct bearing on the subject matter of the continuing education program. This pertains to their relationships with pharmaceutical companies, biomedical device manufactures, or other corporations whose products or services are related to the subject matter of a presentation topic. The intention of this policy does not prevent a speaker with a potential conflict of interest from making presentations; it is merely intended that any potential conflict of interest should be identified openly so the listeners may form their own judgments about the presentation with full disclosure of the facts. It remains for the audience to determine whether the speaker’s outside interests may reflect a possible bias in either the exposition or conclusions presented.
Allan H. Morton , DO– No disclosure identified
Richard Pittsley, MD –In the past 12 months has received speaker honorariums from Abbott Labs, Procter & Gamble, and Sanofi Aventis, was an investigator on a combined research program from Amgen
ACKNOWLEDGEMENTS
The Continuing Medical Education Department would like to thank the following companies for supporting this program through the contribution of educational grants.
Procter & Gamble
